MICHAEL BELL: Open Payments
NPI 1740323237 · UPPER MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 10 payments from 3 companies in 2025. Trend: 2023 $98 · 2024 $101 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $184 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: UZEDY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
